These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 18837831)

  • 1. Decline in the risk of hepatitis A virus infection in China, a country with booming economy and changing lifestyles.
    Xu ZY; Wang XY; Liu CQ; Li YT; Zhuang FC
    J Viral Hepat; 2008 Oct; 15 Suppl 2():33-7. PubMed ID: 18837831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of hepatitis A vaccination programs for migrant children on the incidence of hepatitis A in The Netherlands.
    Suijkerbuijk AW; Lindeboom R; van Steenbergen JE; Sonder GJ; Doorduyn Y
    Eur J Public Health; 2009 Jun; 19(3):240-4. PubMed ID: 19174503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing incidence of hepatitis A in Korean adults.
    Kim YJ; Lee HS
    Intervirology; 2010; 53(1):10-4. PubMed ID: 20068335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Protective efficacy of H2 strain live attenuated hepatitis A vaccines in an outbreak of hepatitis A].
    Zhao Y; Meng Z; Guo J; Wang X; Duo C; Liu H; Yao J; Chai S; Zhu H; Xu Z
    Zhonghua Yu Fang Yi Xue Za Zhi; 2000 May; 34(3):144-6. PubMed ID: 11860920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should Brazilian patients with chronic hepatitis C virus infection be vaccinated against hepatitis A virus?
    Villar LM; de Melo MM; Calado IA; de Almeida AJ; Lampe E; Gaspar AM
    J Gastroenterol Hepatol; 2009 Feb; 24(2):238-42. PubMed ID: 19215334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cost-effectiveness analysis of universal childhood hepatitis A vaccination in China.
    Zhuang GH; Pan XJ; Wang XL
    Vaccine; 2008 Aug; 26(35):4608-16. PubMed ID: 18597903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis A in Jerusalem--the exception that proves the rule?
    Stein-Zamir C; Shoob H; Nubani N; Zentner G
    Vaccine; 2008 Sep; 26(41):5241-3. PubMed ID: 18691626
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatitis a in Korea: epidemiological shift and call for vaccine strategy.
    Lee D; Cho YA; Park Y; Hwang JH; Kim JW; Kim NY; Lee DH; Lee W; Jeong SH
    Intervirology; 2008; 51(2):70-4. PubMed ID: 18434743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epaxal: a virosomal vaccine to prevent hepatitis A infection.
    Bovier PA
    Expert Rev Vaccines; 2008 Oct; 7(8):1141-50. PubMed ID: 18844588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epidemiological effects of live attenuated hepatitis A vaccine (H(2)-strain): results of A 10-year observation].
    Zhuang F; Jiang Q; Gong Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Jun; 22(3):188-90. PubMed ID: 11860874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of a hepatitis A vaccination program for migrant children in Amsterdam, The Netherlands (1992-2004).
    Sonder GJ; Bovée LP; Baayen TD; Coutinho RA; van den Hoek JA
    Vaccine; 2006 Jun; 24(23):4962-8. PubMed ID: 16675076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The relationship between changing of anti-HAV in population and prevalence of hepatitis A].
    Li L
    Zhonghua Yu Fang Yi Xue Za Zhi; 1989 May; 23(3):139-40. PubMed ID: 2555117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epidemiology and cost-effectiveness analysis of hepatitis A vaccination in Liuzhou City].
    Li X; Xu Z; Hofman A
    Zhonghua Liu Xing Bing Xue Za Zhi; 1998 Apr; 19(2):93-6. PubMed ID: 10322718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of hepatitis A virus antibody among Bangladeshi children and young adults warrants pre-immunization screening of antibody in HAV vaccination strategy.
    Ahmed M; Munshi SU; Nessa A; Ullah MS; Tabassum S; Islam MN
    Indian J Med Microbiol; 2009; 27(1):48-50. PubMed ID: 19172060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation on the role of hepatitis A vaccine in the prevention and control of hepatitis A in Tianjin city].
    Zhang ZL; Zhu XJ; Ding YX; Xie XH; Gao ZG; Li YC; Zhang Y; Xia WD; Liu Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):1000-3. PubMed ID: 18399149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunogenicity and efficacy of two live attenuated hepatitis A vaccines (H(2) strains and LA-1 strains)].
    Xu Z; Wang X; Li R; Meng Z; Zhang Y; Gong J; Ma J; Li Y; Zhao S; Li Y; Zhao Y; Huang Q; Luo D; Xia J; Liu H; Liu X; Ouyang P
    Zhonghua Yi Xue Za Zhi; 2002 May; 82(10):678-81. PubMed ID: 12133465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on the effects of controlling hepatitis A epidemics by building the colony immune defence].
    Chen YZ; Jiang RJ; Yu WX; Li CH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 May; 24(5):366-9. PubMed ID: 12820928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Further survey on efficacy of attenuated live hepatitis A vaccines].
    Meng Z; Yao J; Zhao Y
    Zhonghua Yi Xue Za Zhi; 2000 Jan; 80(1):9-11. PubMed ID: 11798728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis A disease following the implementation of universal vaccination: who is at risk?
    Mor Z; Srur S; Dagan R; Rishpon S
    J Viral Hepat; 2010 Apr; 17(4):293-7. PubMed ID: 19691457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status of liver diseases in Korea: hepatitis A.
    Kwon SY
    Korean J Hepatol; 2009 Dec; 15 Suppl 6():S7-12. PubMed ID: 20037282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.